# Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/docetaxel-plus-nintedanib-versus-docetaxel-plus-placebo-in-patients-with/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Martin Reck,R. Kaiser,Anders Mellemgaard,Jean‐Yves Douillard,С. В. Орлов,Maciej Krzakowski,Joachim von Pawel,Maya Gottfried,Igor Bondarenko,Meilin Liao,Claudia-Nanette Gann,José Barrueco,Birgit Gaschler‐Markefski,Silvia Novello |
| Citations | 950 |
| DOI | 10.1016/s1470-2045(13)70586-2 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://hdl.handle.net/2318/151382 |
| OpenAlex ID | https://openalex.org/W2170030318 |
| PMID | 24411639 |
| Type | article |
| Year | 2014 |

## Paper authors

- [Silvia Novello](https://scholariq.org/researchers/silvia-novello/)

## Paper journal

- [The Lancet Oncology](https://scholariq.org/journals/the-lancet-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.